Skip to main content
26 February 2021
Last updated:
Friday 26 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Merus concludes bispecific antibody deal with Lilly

Wednesday 20 January 2021
Country

Netherlands

Merus NV of the Netherlands has secured a research collaboration with Eli Lilly and Co to develop three bispecific antibody therapies for cancer.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Company News
Finance, Grants, Deals

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.